Viewing nowRosaco 50mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Samsung Pharmaceutical Co., Ltd.

MFDS item code 201309020 · Approved 2013.08.28
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
This medication effectively treats hypertension and also helps with kidney diseases associated with type 2 diabetes. It contributes to the prevention of cardiovascular complications by managing hypertension and is used to protect kidney function and maintain health.
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and given orally twice daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this drug alone, it may be administered in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No adjustment of the initial dose is required in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age and older weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older weighing 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, pregnant women or women who may become pregnant should not take it. Patients with severely impaired liver function, hereditary angioedema, primary hyperaldosteronism, or certain other conditions should not use this medication. Caution is required for elderly patients, those with weakened kidney function, and hyperkalemia patients, as there is a risk of too low blood pressure or deteriorating kidney function; regular check-ups are necessary. This medication lowers blood pressure, but side effects such as dizziness, muscle cramps, back pain, cough, and indigestion may occur; consult a healthcare professional if any unusual symptoms arise. There may be interactions with other medications, especially when taken with potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), or lithium. This medication may pose a risk to the fetus during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy, and consultation with a doctor is recommended. Breastfeeding women should also avoid this medication if possible. In case of overdose, symptoms such as low blood pressure and bradycardia may occur; it is crucial to visit a healthcare facility for appropriate treatment immediately. During treatment with this medication, there may be sudden drops in blood pressure that could lead to fainting or dizziness; therefore, caution is advised when driving or operating dangerous machinery. Keep out of reach of children, and it is important not to change or stop the dosage without a doctor's instruction.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius. Proper storage will help retain the medication's effectiveness.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Samsung Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.